Trials / Completed
CompletedNCT01419847
Topical Penlac Nail Lacquer for Onychomycosis in Children
A Prospective, Double-blind, Placebo-controlled Trial of Topical Penlac Nail Lacquer for Therapy of Onychomycosis in Children
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Rady Children's Hospital, San Diego · Academic / Other
- Sex
- All
- Age
- 2 Years – 16 Years
- Healthy volunteers
- Not accepted
Summary
Five months of therapy is sufficient to treat onychomycosis in children. Topical therapy of onychomycosis in children with Penlac nail lacquer has comparable efficacy and a superior cost and safety profile compared to systemic therapy.
Detailed description
Therapeutic trials for the treatment of onychomycosis have been conducted in the adult population, but there is limited data available in the pediatric population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ciclopirox | |
| DRUG | Placebo |
Timeline
- Start date
- 2002-03-01
- Primary completion
- 2005-12-01
- Completion
- 2006-05-01
- First posted
- 2011-08-18
- Last updated
- 2011-08-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01419847. Inclusion in this directory is not an endorsement.